mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.2 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.2 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.083 |
0.2 |